Xgene Pharmaceutical
About:
Xgene Pharmaceutical is a pharmaceutical company.
Website: https://xgenepharm.com
Top Investors: Taiwania Capital Management Corporation, Morningside Venture Investments, GSR United Capital, TF Capital, Hengxu Capital
Description:
Xgene Pharmaceutical is a late-clinical stage, venture-backed international company that uses proprietary linker technology to develop novel, multimodal conjugated molecules for the treatment of neurological disorders. Current programs are aimed at increasing the efficacy and tolerability of pain medications.
Total Funding Amount:
$60M
Estimated Revenue Range:
$10M to $50M
Headquarters Location:
Shanghai, Shanghai, China
Founded Date:
2016-08-18
Founders:
Feng Xu, Jinghong Hsu
Number of Employees:
1-10
Last Funding Date:
2022-08-15
IPO Status:
Private
Industries:
© 2025 bioDAO.ai